Controversy in the Pharmacy Industry

1142 WordsFeb 22, 20135 Pages
The pharmaceutical industry is a highly competitive business and its success depends on the sales and marketing of each particular drug. But more recently, there have been a rise in issues relating to the rapid growth of pharmaceutical use, spending for drugs and related concerns about drug prices, among many other issues relating to scandal with vaccinations. The pharmaceutical industry may have their issues, but there has been a lot of good to come from this industry when it comes to one’s health. There are a lot of pros to the pharmacy industry. The most important benefit of pharmaceutical drugs is the fact that it helps enhance one’s health. There have been great health outcomes from using the drugs. According to the U.S. Bureau of…show more content…
This has a huge impact on American tax payers, costing us over $60 million of our tax dollars. Nicholas Capaldi (2003) addresses another issue within the pharmaceutical industry, stating that it is caught up in a “perfect storm.” He also mentions how there are a various of interest groups that have conspired to present this industry as profiteers who “……(a) spend obscene sums on marketing1 instead of research, (b) engage in differential pricing at home and abroad in an effort to gouge the American consumer, and (c) deprive developing countries of life-saving medicines” (2003). Because of the high costs of medications, as a result, this is forcing the pharmaceutical industry to make medications more affordable to consumers. Another issue regarding the pharmaceutical industry is scandal. In 2009, there was a huge pandemic of the H1N1 virus, also known as the “Swine Flu.” According to the U.S. Centers for Disease Control (2009), 3,900 U.S. residents have died from swine flu; five percent of that being children. The distribution for the H1N1 (swine flu) vaccine was one of the biggest scandals. According to SocialistWorker.org (2009), “President Obama promised in July that 160 million doses of swine flu vaccine would be available by the end of October. The Department of Health and Human Services revised that estimate to 40 million and then to 28 million--enough doses

More about Controversy in the Pharmacy Industry

Open Document